Dr. Renjini Chandra, MD

NPI: 1831181619
Total Payments
$9,115
2024 Payments
$1,319
Companies
62
Transactions
527
Medicare Patients
3,442
Medicare Billing
$760,231

Payment Breakdown by Category

Food & Beverage$9,026 (99.0%)
Education$89.38 (1.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $9,026 492 99.0%
Education $89.38 35 1.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,459 90 $0 (2024)
Collegium Pharmaceutical, Inc. $855.60 80 $0 (2024)
Amgen Inc. $819.48 19 $0 (2022)
GRT US Holding, Inc. $495.84 18 $0 (2022)
Daiichi Sankyo Inc. $388.39 37 $0 (2019)
PFIZER INC. $320.35 35 $0 (2024)
Lundbeck LLC $309.97 15 $0 (2024)
Allergan, Inc. $308.10 11 $0 (2021)
SCILEX PHARMACEUTICALS INC. $264.72 15 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $238.75 14 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,319 84 ABBVIE INC. ($455.21)
2023 $1,112 86 AbbVie Inc. ($347.12)
2022 $1,744 95 ABBVIE INC. ($557.47)
2021 $677.36 34 Amgen Inc. ($104.83)
2020 $684.74 31 Allergan, Inc. ($216.39)
2019 $1,249 51 Amgen Inc. ($342.56)
2018 $1,067 67 Collegium Pharmaceutical, Inc. ($177.27)
2017 $1,262 79 Daiichi Sankyo Inc. ($213.68)

All Payment Transactions

527 individual payment records from CMS Open Payments — Page 1 of 22

Date Company Product Nature Form Amount Type
12/20/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $8.70 General
Category: Opioid Analgesic
12/16/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $15.69 General
Category: NEUROLOGY
12/16/2024 Forte Bio-Pharma LLC NALOCET (Drug), PROLATE, PROLATE Food and Beverage In-kind items and services $11.06 General
Category: PAIN
12/12/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $8.47 General
Category: Opioid Analgesic
12/05/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $5.76 General
Category: Opioid Analgesic
12/02/2024 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $14.05 General
Category: PAIN
11/25/2024 Forte Bio-Pharma LLC NALOCET (Drug), PROLATE, PROLATE Food and Beverage In-kind items and services $22.93 General
Category: PAIN
11/21/2024 ABBVIE INC. QULIPTA (Drug), BOTOX Food and Beverage In-kind items and services $5.76 General
Category: NEUROSCIENCE
11/20/2024 Forte Bio-Pharma LLC NALOCET (Drug), PROLATE, PROLATE Food and Beverage In-kind items and services $6.20 General
Category: PAIN
11/18/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $22.05 General
Category: Opioid Analgesic
11/14/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $6.42 General
Category: Opioid Analgesic
11/04/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $15.90 General
Category: NEUROSCIENCE
10/28/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $13.43 General
Category: NEUROLOGY
10/24/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $8.92 General
Category: Opioid Analgesic
10/23/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $18.39 General
Category: Analgesic
10/22/2024 Forte Bio-Pharma LLC NALOCET (Drug), PROLATE, PROLATE Food and Beverage In-kind items and services $3.95 General
Category: PAIN
10/21/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $13.52 General
Category: NEUROSCIENCE
10/16/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $16.20 General
Category: NEUROSCIENCE
10/09/2024 Forte Bio-Pharma LLC NALOCET (Drug), PROLATE, PROLATE Food and Beverage In-kind items and services $10.24 General
Category: PAIN
10/07/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $15.35 General
Category: NEUROSCIENCE
10/03/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $6.51 General
Category: Opioid Analgesic
09/30/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $17.24 General
Category: Analgesic
09/23/2024 Forte Bio-Pharma LLC PROLATE (Drug), NALOCET, PROLATE Food and Beverage In-kind items and services $24.53 General
Category: PAIN
09/19/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $81.02 General
Category: NEUROSCIENCE
09/18/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $7.28 General
Category: Opioid Analgesic

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 940 4,141 $675,870 $257,562
2022 10 961 4,174 $676,662 $257,314
2021 10 840 2,851 $405,361 $167,091
2020 10 701 1,820 $253,002 $78,264
Total Patients
3,442
Total Services
12,986
Medicare Billing
$760,231
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 357 2,624 $577,280 $223,490 38.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 86 165 $23,100 $9,921 42.9%
80305 Testing for presence of drug, read by direct observation Office 2023 302 692 $20,760 $8,513 41.0%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 58 58 $23,200 $8,198 35.3%
20553 Injection of trigger points, 3 or more muscles Office 2023 39 75 $16,275 $3,019 18.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 23 24 $6,720 $2,969 44.2%
20610 Aspiration and/or injection of fluid from large joint Office 2023 16 28 $6,160 $1,312 21.3%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 22 170 $850.00 $132.85 15.6%
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg Office 2023 37 305 $1,525 $6.23 0.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 343 2,525 $555,500 $216,659 39.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 126 253 $35,420 $13,870 39.2%
80305 Testing for presence of drug, read by direct observation Office 2022 277 745 $22,350 $9,185 41.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 47 47 $18,800 $7,406 39.4%
20553 Injection of trigger points, 3 or more muscles Office 2022 51 106 $23,002 $4,551 19.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 27 27 $7,560 $2,804 37.1%
20610 Aspiration and/or injection of fluid from large joint Office 2022 22 30 $7,700 $1,587 20.6%
95909 Nerve conduction, 5-6 studies Office 2022 11 11 $4,180 $1,147 27.4%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2022 18 109 $545.00 $100.20 18.4%
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg Office 2022 39 321 $1,605 $5.73 0.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 280 1,291 $284,020 $122,776 43.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 154 338 $47,320 $21,262 44.9%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 37 37 $14,800 $5,831 39.4%
80305 Testing for presence of drug, read by direct observation Office 2021 194 410 $12,300 $5,166 42.0%
20553 Injections of trigger points in 3 or more muscles Office 2021 54 115 $24,955 $4,998 20.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 31 33 $9,240 $4,025 43.6%

About Dr. Renjini Chandra, MD

Dr. Renjini Chandra, MD is a Physical Medicine & Rehabilitation healthcare provider based in Overland Park, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831181619.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Renjini Chandra, MD has received a total of $9,115 in payments from pharmaceutical and medical device companies, with $1,319 received in 2024. These payments were reported across 527 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($9,026).

As a Medicare-enrolled provider, Chandra has provided services to 3,442 Medicare beneficiaries, totaling 12,986 services with total Medicare billing of $760,231. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Physical Medicine & Rehabilitation
  • Other Specialties Physical Medicine & Rehabilitation
  • Location Overland Park, KS
  • Active Since 08/18/2005
  • Last Updated 10/16/2023
  • Taxonomy Code 208100000X
  • Entity Type Individual
  • NPI Number 1831181619

Products in Payments

  • UBRELVY (Drug) $1,055
  • Aimovig (Biological) $790.40
  • QULIPTA (Drug) $514.43
  • Qutenza (Drug) $495.84
  • NURTEC ODT (Drug) $344.29
  • XTAMPZA (Drug) $325.28
  • VYEPTI (Biological) $309.97
  • Morphabond ER (Drug) $300.51
  • Xtampza ER (Drug) $244.02
  • RELISTOR (Drug) $221.91
  • ZTLido (Drug) $209.74
  • Belbuca (Drug) $207.98
  • NALOCET (Drug) $195.20
  • BRIXADI (Drug) $159.04
  • Lucemyra/Lofexidine (Drug) $156.09
  • Levorphanol (Drug) $151.56
  • Seglentis (Drug) $136.18
  • Nucynta (Drug) $131.86
  • TROKENDI XR (Drug) $129.15
  • Movantik (Drug) $129.09

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physical Medicine & Rehabilitation Doctors in Overland Park